Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DP-b99 (D-Pharm).

Pollen K F Yeung1

  • 1Pharmacokinetics & Metabolism Laboratory, College of Pharmacy, Burbridge Building, Dalhousie University, Halifax, NS B3H-3J5, Canada. pollen.yeung@dal.ca

Current Opinion in Investigational Drugs (London, England : 2000)
|February 27, 2004
PubMed
Summary
This summary is machine-generated.

DP-b99, a BAPTA derivative, is being developed as a neuroprotectant. Ongoing clinical trials investigate its potential for treating stroke, head trauma, and neurological damage.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pilot Study to Assess Adenosine 5'-triphosphate Metabolism in Red Blood Cells as a Drug Target for Potential Cardiovascular Protection.

Cardiovascular & hematological disorders drug targets·2015
Same author

Diltiazem reduces mortality and breakdown of ATP in red blood cell induced by isoproterenol in a freely moving rat model in vivo.

Metabolites·2014
Same author

Effect of acute exercise on cardiovascular hemodynamic and red blood cell concentrations of purine nucleotides in hypertensive compared with normotensives rats.

Therapeutic advances in cardiovascular disease·2013
Same author

Comparing pharmacokinetics and metabolism of diltiazem in normotensive Sprague Dawley and Wistar Kyoto rats vs. spontaneously hypertensive rats in vivo.

Drug metabolism and drug interactions·2011
Same author

Exercise improves hemodynamic profiles and increases red blood cell concentrations of purine nucleotides in a rodent model.

Therapeutic advances in cardiovascular disease·2010
Same author

Pharmacokinetics and metabolism of diltiazem following multiple doses: comparing normotensive rat vs. hypertensive rat models in vivo.

Drug metabolism letters·2009

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • DP-b99 is a novel derivative of BAPTA, a known calcium chelator.
  • Calcium dysregulation plays a critical role in various neurological injuries.

Purpose of the Study:

  • To evaluate DP-b99 as a potential neuroprotective agent.
  • To assess the efficacy of DP-b99 in treating conditions like stroke and traumatic brain injury.

Main Methods:

  • Development of DP-b99 as a therapeutic agent.
  • Phase II clinical trials for acute stroke and traumatic brain injury.

Main Results:

  • DP-b99 is under active clinical investigation.
  • Clinical trials are exploring its therapeutic potential in neurological conditions.

Conclusions:

  • DP-b99 shows promise as a neuroprotectant.
  • Further clinical evaluation is warranted for stroke, head trauma, and related neurological damage.